LAG3 and cancer: Overexpression of LAG-3 and/or PD-1 has been observed in many human cancers, including melanoma, non-small cell lung cancer (NSCLC), colorectal cancer (CRC), breast cancer, and Hodgkin lymphoma [11–13].